Portfolio Holdings & Fund Performance - venBio Global Strategic Fund II L.P.

List of top 200 securities held by venBio Global Strategic Fund II L.P.:

  1. Institutional investors with $100 million or more in holdings are required to report their portfolio holdings on a quarterly basis within 45 days of the end of a calendar quarter.
  2. The table below lists top 200 holdings for the reported quarter.
  3. Portfolio values with missing quarterly reports are assigned zero.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#HoldingReport
Quarter		Shares
Held		Value
(Price)		Portfolio
(%)		Shares Vs.
Prev Report		Money
Flow		Holding
History
#
Holding
Report
Quarter
Shares
Held
Value
(Price)
Portfolio
(%)
Shares Vs.
Prev Report
Money
Flow
Holding
History
1VERONA PHARMA PLC SPONSORED AD
VRNA		2017-05-087,000,000$443.17M
($63.31)		75.41%13D/13G
2HARMONY BIOSCIENCES HLDGS INC
HRMY		2022-02-142,740,411$79.198M
($28.90)		13.48%13D/13G
3APELLIS PHARMACEUTICALS INC CO
APLS		2019-02-141,790,102$31.309M
($17.49)		5.33%13D/13G
4AKERO THERAPEUTICS INC
AKRO		2022-09-15714,000$28.282M
($39.61)		4.81%13D/13G
5ALX ONCOLOGY HLDGS INC
ALXO		2020-10-019,799,331$5.684M
($0.58)		0.9671%13D/13G
6VYNE THERAPEUTICS INC PAR$
VYNE		2018-01-2920,299$37.351K
($1.84)		0.0064%Form4
Showing 1 to 6 of 6 entries
×

ERROR